Investors & Media

Whats new.

Press releases

Press releases.

Immutep Announces Improving Results from Stage I of Phase II TACTI-002 Study

September 18th 2020
press releases

Immutep Reports Improving Results from INSIGHT-004 Trial

September 18th 2020
press releases

Immutep and Monash University Receive Grant Funding for LAG-3 Project

August 31st 2020
press releases

Investor updates

Investor updates.

Investor Update - August 2020

August 17th 2020
investor updates

Investor Update - November 2019

November 22nd 2019
investor updates

Investor Update - January 2019

January 31st 2019
investor updates

Analyst reports

Analyst reports.

Bell Potter - Underappreciated immunotherapy player with leadership in LAG-3 (Analyst: Tanushree Jain)

For a copy of this research report please contact tnjain@bellpotter.com.au

September 17th 2020
analyst reports

Taylor Collison - BMS/Dragonfly deal drives valuation upgrade

August 26th 2020
analyst reports

goetzpartners securities - ASCO data underscores efti-PD-1 / L1 synergy

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

June 3rd 2020
analyst reports